Zoetis to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
Zoetis (NYSE: ZTS) will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on September 13, 2022, at 2:05 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations. A replay of the presentation will also be available on the Zoetis website at the conclusion of the event.
About Zoetis
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After 70 years innovating ways to predict, prevent, detect, and treat animal illness, Zoetis continues to stand by those raising and caring for animals worldwide – from livestock farmers to veterinarians and pet owners. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of
ZTS-COR
ZTS-IR
View source version on businesswire.com: https://www.businesswire.com/news/home/20220908005770/en/
Media Contacts:
1-973-443-2742 (o)
william.price@zoetis.com
1-973-443-2777 (o)
kristen.seely@zoetis.com
Investor Contact:
1-973-822-7141 (o)
steve.frank@zoetis.com
1-973-443-2792 (o)
nick.soonthornchai@zoetis.com
Source: